meet Dr. Williams

publications

articles | books, monographs and chapters | abstracts | reviews | poster presentations
ARTICLES
Mazonson P, Williams M, et al. Myxedema coma during long-term amiodarone therapy. Am J. Med 1984;77.
Williams ML, Woelfel A, Cascio W, Simpson RJ Jr., Gettes LS, Foster JR. Amiodarone during prolonged resuscitation from cardiac arrest.
Ann Int Med 1989;ll0:839-862.
Stone P, Kleimon N, Kronenberg M, Willeson J, Williams M, Prior MJ, Thompson B, Braunbald T. Effect of Gender, Race, Age on the Natural history of unstable Angina and Non Q-Wave MI: The T3 Registry. American College of Cardiology, JACC, 1993 Vol 21 No. 2 (Suppl A) P453A.
Gunnarsson PS, Sawyer WT, Montague D, Williams ML, Dupuis RE, Caiola SM. Appropriate use of heparin: Empiric versus nomogram based dosing. Archives of Intern Med 1994;155:526-32.
The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardinal infarction. Circulation 1994;89:1545-1556.
Treatment of Myocardial Infarction in the United States (1990 to 1993). Circulation 1994;90:2103-2114.
Antman E, for the TIMI 9A investigators. Hirudin in Acute Myocardial Infarction, Safety Report From the Thromobolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trail. Circulation 1994;90:1624-1630
Williams ML, O'Meara JJ, Tate DA, Simpson RJ. Acute Myocardial infarction, A Guide for North Carolina Doctors. NCMJ August, 1995, Volume 56, Number 8.
Maynard C. Weaver D. Lambrew C, Bowlby L, Rogers W, Rubison M, for the participants in the National Registry of Myocardial infarction. Factors Influencing the Time to Administration of Thromobolytic Therapy With Recombinant Tissue Plasminogen Activator (Data from the National Registry of Myocardial infarction). The American Journal of Cardiology Volume 76, September, 1995.
Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ, for the Participants in the National Registry of Myocardinal infarction. Recent Age-Related Trends in the Use of Thromobolytic Therapy in Patients Who have Had Acute Myocardial infarction. Ann Intern Med 1996;124:283-291.
Cannon CP, McCabe CH, Stone PH, Rogers WJ, Schactman M, Thompson BW, Pearce DJ, Diber DJ, Kells C, Feldman T, Williams M, Gibson RS, Kronenberge MW, Ganz LI, Anderson HV, Braunwald E The Electrocardiogram Predicts One-Year Outcome of Patients with Unstable Angina an Non-Q Wave Myocardial Infarction: Results of the TIMI III Registry ECG Ancillary Study. J Am Coll Cardiol 1997;30:133-40 Williams ML, Hill G, Jackson MJ. Acute Myocardial Infarction at a University Hospital: Effect of Race on Short-term Mortality. JAAMP 2000;11:1-4.

OPUS-TIMI 16 Investigators. Oral Glycoprotein IIb/IIIa Inhibition with Orbofiban in Patients with unstable coronary syndromes (OPUS-TIMI 16) Trial. Circulation 2000;102:149-156.

TACTICS-TIMI 18 Investigators et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein 2b/3a inhibitor tirofiban. N Eng J Med 2001;344:1879-1887.

BOOKS, MONOGRAPHS AND CHAPTERS

Williams ML, Tate DA. Acute Interventions in Myocardial Infarction. Emergency Medicine, A Comprehensive Study Guide, 4th Edition, 1995.

ABSTRACTS

Williams ML, Gettes LS, Johnson T, Fleet WF, Cascio W. Dose-dependent glibenclamide reduction in extracellular potassium rise and activation delay in the in-situ pig heart. Circulation (Supp 4) 1991;II-551.

Theroux P, Kleiman N, Shah PK, Williams M, gill J, Rodriguez S, Niederman A, Broderick G, Josephson R, Deschenes N, Kitzpatrick V and Sax F. (The MK-852 Investigators.) A Double-Blind, Heparin-Controlled Study of MK-852 in Unstable Angina. American Heart Association. 66th Scientific Sessions (Abstract), 1993.

Lee LV, McCabe CH, Antman EM, Koch M. Wilensky R, Stringer K, Hochman J, Mueller HS, Henry TD, Kleiman N, Steingart RM, Wasserman H, Losordo D, Ludbrook P, Doorey A, Rodriguez S, Kennedy P, Rogers WJ, Williams ML, Smitherman TC, Gibson RS, Willerson JT, Edwards S, Henis M, Braunwald E, for the TIMI 6 Investigators, Harvard Medical School, Brigham & Women's Hospital Boston, MA. Initial experience with Hirudin and streptokinase in acute myocardial infarction:

Results of the TIMI 6 Trail. American College of Cardiology 43rd Annual Scientific Session (Abstract), 1994.

Williams DO, Sharaf BL, Braunwald E, Thompson B, Knatterud GL, Buller CE, TIMI 3 Investigators. Percutaneous transluminal coronary angioplasty (PTCA) for acute myocardial ischemia: The TIMI-3 experience. American Heart Association 67th Scientific Sessions (Abstract), 1994.

Stone P, Kleiman N, Kronenberg M, Anderson HV, Williams M, Knatterud G, Thompson B, Braunwald E. The influence of race and age on the management and outcome of patients with unstable angina and non-Q-wave MI. TIMI III Registry. American Heart Association 67th Scientific Sessions (Abstract), 1994.

Anderson HV, Cannon C, Williams D, Stone P, McCabe C, Knatterud G, Thompson B, Willerson J, Braunwald E. One-year results of the TIMI-IIIB clinical trail. American Heart Association 67th Scientific Sessions (Abstract), 1994.

Cannon CP, Stone PH, Rogers WJ, McCabe C, Schactman M, Diver DJ, Kells CM, Williams M, Feldman T, Kronenberg M, Pearce DJ, Gibson RS, ECG as a Predictor of Outcome in Acute Coronary Syndromes. Results of the TIMI III Registry ECG Ancillary Study. American College of Cardiology 43rd Annual Scientific Session (Abstract), 1994.

Williams ML, Engle C, Cascio W, Gettes L, Experimental Cardiology Group, University of North Carolina, Chapel Hill, NC. Lack of Effect of Pinacidil on Extra Cellular K+

Accumulation During the Early Phase of Acute No Flow Ishemia in the In-Situ Pig. Journal of the Association of Academic Minority Physicians Volume 4, Number 4, 1993.

Williams ML, Hill G, Jackson M, Griggs TR. Racial Differences in Short Term Outcomes for Acute Myocardial Infarction. Circulation (Supp 8), 1995; 1-437-2087.

Williams ML, Ademokekum J, Jackson M, Hill G The Impact of a Chest Pain Unit Without Walls. Fourth National Gongress of Chest Pain Centers in Emergency Departments. Heart Attack: The Public Health Challenge for The New Millinnium. 2000:47.
Youssef M, Willliams ML, Morris MT, Ahmad U, Li W, Ertel N. Racial differences in compliance to NCEP-II recommendations for secondary preventin at a veteran affair medical center. Ethnicity & Disease 2001;11:339.

Williams ML, Hill G, Jackson M. Comparison of the severity of coronary artery disease in acute myocardial infarction by race. Ethnicity & Disease 2001;11:339.
Williams ML, Hill G, Jackson M. The Impact of an Acute Myocardial Infarction Pathway on Racial Outcomes at a University Hospital. Ethnicity & Disease 2006, scheduled for print.

REVIEWS

Williams ML, Lawton JJ, Griggs TR. Dilemmas in the Management of a Patient with Peripheral Vascular Disease. JCOM July/August 1995.

POSTER PRESENTATIONS

Williams ML, Cardiology and EOVA. The Help Project. This looked at the results of several interventions to improve outcome and satisfaction for end of life CHF patients. Presented: VA National Leadership Conference on Pain Management and End of Life Care. November 2-5, 1999.

Marcus L. Williams, M.D.
home | meet Dr. Williams | services | health info. | for your visit | contact Us | links | sitemap
Copyright 2008